Pneumococcal Vaccine Earns Positive Opinion from the European Union Committee for Medicinal Products for Human Use
Heather Platt, MD, discusses Merck’s latest achievement with Capvaxive and its potential to significantly reduce invasive pneumococcal disease and pneumonia in high-risk adult populations across Europe.